Notably, lactate dehydrogenase A (LDHA), a pivotal enzyme in the final phase of this metabolic shift, is prevalent in multiple cancer cells and is intimately linked to tumor dimensions and clinical outcomes (46, 47). This evidence concerns the gene LDHA and neoplasm.